BMC Infectious Diseases

official impact factor 2.83

Section Editors

  • Fabrice Carrat, INSERM
  • Susanna Esposito, University of Milan
  • Sanjeev Krishna, St. George's, University of London
  • Stephen Lawn, Institute of Infectious Disease and Molecular Medicine
  • Sepehr Tabrizi, The Royal Women's Hospital
  • Carlo Torti, University of Brescia

Executive Editor

  • Diana Marshall, BioMed Central

Articles

There has been an error retrieving the data. Please try again.
  • Image attributed to: i stock

    Defining HIV-associated neurocognitive disorders

    Magnus Gisslen and colleagues discuss the potential overestimation of asymptomatic neurocognitive impairment (ANI) in HIV patients, arguing that the current definition could lead to a high false-positive rate. This debate is discussed further by Carlo Torti and colleagues in BMC Medicine.

    BMC Infectious Diseases 2011, 11:356
  • Image attributed to: Pills from Flickr by Rodrigo Senna

    Non-integrated services delay ART initiation

    Delays in starting antiretroviral therapy (ART) in patients with HIV-associated tuberculosis are prolonged when patients are referred from TB clinics to separate ART clinics, emphasizing the importance of integrating the two services for timely ART initiation.

    BMC Infectious Diseases 2011, 11:258

RSS

Comments

View more comments

Scope



BMC Infectious Diseases is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of infectious and sexually transmitted diseases in humans, as well as related molecular genetics, pathophysiology, and epidemiology.

Quote

Sally Blower
"I strongly believe in the internet and open-access publishing in order to achieve scientific outreach both within academia and outside academia. Open-access allows anyone in the world with access to a computer to access scientific research. These innovative journals are becoming extremely successful and will change the nature of scientific publishing and increase the accessibility of science."

Professor Sally Blower
Semel Institute for Neuroscience & Human Behavior,
UCLA David Geffen School of Medicine, USA